<i>Human Vaccines & Immunotherapeutics</i>awards Top Reviewer of the Year
Notice bibliographique
Résumé
Human Vaccines & Immunotherapeutics (HV&I, formerly Human Vaccines) recently started its 8th year of publication. Each month, we publish a mix of high-quality original research and solicited content including timely reviews, commentaries, news, portraits, and much more. HV&I has become well-established in the vaccine community as an important forum for companies, academics, governmental and non-governmental organizations in this field. Our journal’s unique and exclusive focus on vaccines and immunotherapeutics for human use coupled with the rapid turnaround from submission through peer review to acceptance has allowed HV&I to continuously increase its content and progressively improve its standing relative to other journals in the field. Obviously, the successful development of HV&I would not have been possible without the many scientists who have served as peer reviewers for HV&I. We want to take this opportunity to thank all our reviewers for their time and commitment. All peer reviewers of 2011 are listed below. In particular, we are very pleased to recognize Dr. Arístides Aguilar Betancourt (Centre for Genetic Engineering & Biotechnology, Biomedical Research Branch, Vaccines Division, Havana, Cuba) as Top Reviewer 2011 for Human Vaccines & Immunotherapeutics. On behalf of Landes Bioscience, we want to thank him for his commitment with a special gift. Previous Awardees were Drs. Brian Greenwood (London School of Hygiene and Tropical Medicine, UK), Brian Ward (McGill University, Montreal, Canada), James Tartaglia (Sanofi-Pasteur, Toronto, Canada), Joel Bozue (USAMRIID Bacteriology, Fort Detrick, MD, USA), and Mark Kane (Consultant, Mercer Island, Seattle, WA, USA).Human Vaccines & Immunotherapeutics (HV&I, formerly Human Vaccines) recently started its 8th year of publication. Each month, we publish a mix of high-quality original research and solicited content including timely reviews, commentaries, news, portraits, and much more. HV&I has become well-established in the vaccine community as an important forum for companies, academics, governmental and non-governmental organizations in this field. Our journal’s unique and exclusive focus on vaccines and immunotherapeutics for human use coupled with the rapid turnaround from submission through peer review to acceptance has allowed HV&I to continuously increase its content and progressively improve its standing relative to other journals in the field. Obviously, the successful development of HV&I would not have been possible without the many scientists who have served as peer reviewers for HV&I. We want to take this opportunity to thank all our reviewers for their time and commitment. All peer reviewers of 2011 are listed below. In particular, we are very pleased to recognize Dr. Arístides Aguilar Betancourt (Centre for Genetic Engineering & Biotechnology, Biomedical Research Branch, Vaccines Division, Havana, Cuba) as Top Reviewer 2011 for Human Vaccines & Immunotherapeutics. On behalf of Landes Bioscience, we want to thank him for his commitment with a special gift. Previous Awardees were Drs. Brian Greenwood (London School of Hygiene and Tropical Medicine, UK), Brian Ward (McGill University, Montreal, Canada), James Tartaglia (Sanofi-Pasteur, Toronto, Canada), Joel Bozue (USAMRIID Bacteriology, Fort Detrick, MD, USA), and Mark Kane (Consultant, Mercer Island, Seattle, WA, USA).
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,012 | 0,066 |
| Méta-épidémiologie (sens strict) | 0,002 | 0,001 |
| Méta-épidémiologie (sens large) | 0,002 | 0,002 |
| Bibliométrie | 0,006 | 0,003 |
| Études des sciences et des technologies | 0,003 | 0,001 |
| Communication savante | 0,014 | 0,004 |
| Science ouverte | 0,003 | 0,003 |
| Intégrité de la recherche | 0,005 | 0,004 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,103 | 0,094 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».